Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets Jun 1, 2016 07:00AM
Horizon Pharma (HZNP) Receives USPTO Notice of Allowance for VIMOVO-Related Patent Mar 14, 2016 07:19AM
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets Mar 14, 2016 07:00AM